Plasma glycoproteomics delivers high-specificity disease biomarkers by detecting site-specific glycosylation abnormalities.
Wessels HJCT, Kulkarni P, van Dael M, Suppers A, Willems E, Zijlstra F, Kragt E, Gloerich J, Schmit PO, Pengelley S, Marx K, van Gool AJ, Lefeber DJ.
Wessels HJCT, et al. Among authors: gloerich j.
J Adv Res. 2023 Sep 6:S2090-1232(23)00239-4. doi: 10.1016/j.jare.2023.09.002. Online ahead of print.
J Adv Res. 2023.
PMID: 37683725
Free article.